Implantable Sensor System for
Wireless Restenosis Detection

Product

Implantation


The sensor system is implanted in a coronary or peripheral artery during stent implantation or balloon angioplasty.

The read out device then is placed on the body where the stent is implanted.

Data Acquisition


It transmits these data to a cloud service. Based on the patient specific data, the restenosis degree will be calculated.

The data will be transfered back to the cardiologist or physician within a minute.


Diagnosis


It will also be accessable via web interface for clinicians, physicians and patients.

It will be possible to derive trends and detect further important parameters in relation to restenosis.

One System ...

... Several Advantages

vs. State-of-the-Art

  • Measurements in short intervals
  • Early prediction of clogging
  • Easy handling, precise and fast diagnosis

For Physicians

  • Determination of trends and correlation with further vital parameters is possible
  • The restenosis treatment may be induced in an earlier stage
  • Success of therapy is detectable and can be monitored

For Patients

  • Improves life comfort and sense of security
  • Early detection
  • Reduction of time-consuming check-ups, e.g. physical performance tests, ultrasonic testing

Time-consuming and expensive follow-up examinations can be avoided in the future.

Videopresentation

Team and Product

( 4 min )

Team

Alexej Domnich, PhD

CEO / CTO and Inventor

Biomedical engineer

  • 16+ years management and R&D experience in MedTech and Life Science at  Fraunhofer IPA and Life Science Inkubator
  • Biomedical engineering
  • Mechatronics
  • Automation technology
  • Control engineering
  • Software development

Johannes Baulmann, MD

Chief Medical Officer

Expert Internal Medicine/ Angiology

  • Specialist for internal medicine, angiology
  • Research on cardiovascular risk
  • 23+ years experience in executive leadership
  • Executive Board DeGAG
  • Co-Founder Redwave-Medical GmbH

Nikolaus Fischer-Wasels, CFA

CFO & Business Development

  • 11+ years experience in financial services consulting at big 4 accounting forms
  • Certified Financial Analyst (CF) and Financial Risk Manager (FRM).
  • Co-Founder Clemedi AG

Saad Salem

Mechanical Engineering

Quality Management / RA

  • 8+ years experience in VesselSens technology
  • Biomedical hardware development
  • Design engineering
  • CAD
  • Project management
  • Quality management (ISO 13485) and regulatory affairs

Advisory Board

Torsten Wohlrab

Senior Partner, Entrepreneur

Start-Up Founder & Advisor

Marketing & Sales expert

  • Founder & CEO @ TRND (European market leader in 1:1 digital marketing)

  • Building, leading & growing profitable organizations
  • Establishing international sales & marketing organizations
  • Due diligence, trade sales & integration into corporates

    20 years Start-Up experience

  • Last Start-up scaled from 2-200 employees, from 1 to 8 countries, 0 EUR to 20 Mio. EUR revenue & then successfully exited to Bertelsmann SE & Co. KGaA

Pavel V. Vodkin

Accomplished Engineering Manager

Co-Founder of Ampliquant INC

  • Accomplished technical leader with 25 years of experience in Medtech area with track record of delivering multiple projects from concept though FDA approval, subsequent design transfer and sustainability phase.

  • Experience in technical de-risking and design optimization for risk management.

  • Accredited investor with multiple positions in early-stage Medtech and biotech stratus with history of successful exits.

  • Cofounder of AmliQuant INC 

Dr. Michael Lichtenberg, MD

Interventional Angiologist

Founder

  • Chief Medical Officer and Director of the Angiology Department and Vascular Center at the Arnsberg Clinic in Arnsberg, Germany
  • 20 years of experience in endovascular interventions
  • Managing Director of the German Society for Angiology in 2017
  • President of the German Society for Angiology from 2020 – 2022
  • Founder of several start-up companies and brands, like PEO, CLI-congress and the European MedTech Start up SharkTank

Dr. Jörg Fregien

CEO, Life Science Inkubator GmbH

Former board member of Bauerfeind AG and Executive Director at Biotronik GmbH

  • Management experience in group structures in the medical technology sector

  • Management of employees with more than 500 employees

  • Founder of three start-up companies

  • Managing director of management, research and financing companies

  • Chairman of the Supervisory Board of InfanDX AG

  • Chairman of the Advisory Board Bomedus GmbH

  • Member of the advisory board of Neuway Pharma GmbH

  • Consultant to various pharmaceutical and medical technology companies

Cooperation

 

 We are currently fundraising for our Seed-phase.

If you are interested in a cooperation – please contact us. 

 

Development Status

Sensor System (Beta Version) 60%
Hardware (Read Out Unit) 80%
Read Out Software 85%
Evaluation Algorithm 90%
Cloud Service / Web Application 95%

Get in Touch